Life Sciences Sector Has Strongest Q1 Since Recession

May 22, 2014
Venture capital funding for the life sciences sector, which includes biotechnology and medical devices, increased 15% in value during the first quarter of 2014, compared to first quarter of 2013, according to a new PwC US report, "Biotech Deals Rising," which includes data from the MoneyTree™ Report from PricewaterhouseCoopers LLP and the NVCA.
Previous Article
Aerospace & Military APU Market to Hit CAGR of 3.92%

APU use the same fuel as the aircraft's engines and generally account for...

Next Article
Conference Board LEI for the U.S. Rise 0.4% in April

The Conference Board Leading Economic Index® (LEI) for the U.S....